biotech

Drug Candidate Against Alzheimer's Disease Goes on Human Trials

Filed in archive Drugs, Vaccines and Therapeutics on July 24, 2006

Drug Candidate Against Alzheimer's Disease Goes on Human Trials
Australian researchers have developed a pill that,hopefully, might stop of delay the onset of Alzheimer's disease. The drug, called PBT2, demonstrated its efficacy in mice trials, and will be entering human trials in sweden in a couple of months.
The institute's tests also showed that PBT2 blocked the interaction between the amyloid protein and metals such as copper and zinc in the brain, stopping the development of Alzheimer's. Amyloid accumulates more rapidly in the presence of metals.

The researchers from the Mental Health Research Institute of Victoria, Australia are working in collaboration with Prana Biotechnology Limited, an Australian biotech firm developing therapies for age-related diseases.

Read the full story from Reuters.


Permalink: Drug Candidate Against Alzheimer's Disease Goes on Human Trials

Tags: alzheimer  aging  biotech  drug  disease  alzheimer+disease  human+trials  drug+candidate 

Vote for Drug Candidate Against Alzheimer's Disease Goes on Human Trials:

  • Currently 8.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.00 out of 1 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells